Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

Clinical trial NCT02251717 · COMPLETED

Trial details

NCT number

NCT02251717

Sponsor

Gilead Sciences

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-10-14

Primary completion

2016-03-24

Enrollment

114

View on ClinicalTrials.gov